Improving the Diagnosis of Diarrhoea in Emergency Rooms

Diarrhoea Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02858609
• Other study ID #: 2012-44
• Status: Completed
• Phase: N/A
• Start date: March 20, 2013
• Est. completion date: October 27, 2022

Study information

• Verified date: October 2022
• Source: Assistance Publique Hopitaux De Marseille
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A point-of-care laboratory (POC) was set at North Hospital, Marseille, France for the diagnosis in less than two hours of diarrhoea caused by known pathogens, close to the reception of Emergency service. In this instance 30% of patients have no etiological diagnosis after the POC diarrhoea tests . This lab has discovered over 200 new species of bacteria in humans, including vector bacteria and opened the field of large Deoxyribonucleic Acid (DNA ) viruses. Also, the laboratory of emerging viruses discovered many Ribonucleic Acid (RNA) viruses transmitted by arthropods. Based on this collection of new pathogens described in POC laboratory, this study proposes to expand the etiological diagnosis strategy of diarrhoea after POC tests.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 354
• Est. completion date: October 27, 2022
• Est. primary completion date: February 8, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patient admitted at hospital for diarrhoea requiring, for the emergency physician, a microbiological examination with a "POC diarrhoea kit."

• Patient who has freely signed the informed written consent

• Patient affiliated to a social security scheme

Exclusion Criteria:

• Pregnant woman, parturient or nursing

• Adult major under guardianship

• Patient deprived of liberty under court order

• Patient refusing or unable to sign the informed consent form.

Related Conditions & MeSH terms

• Diarrhea
• Diarrhoea

Intervention

Other:
• Nasopharyngeal Swab

Locations

Country	Name	City	State
France	Assistance Publique Hopitaux de Marseille	Marseille

Sponsors (1)

Lead Sponsor	Collaborator
Assistance Publique Hopitaux De Marseille

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage of patients admitted in emergency rooms for diarrhoea with confirmed etiological diagnosis		1 day